Scientists test how new HIV drug works with common medications
NCT ID NCT07066722
Summary
This early study tested how a new HIV drug candidate behaves in healthy adults. Researchers examined how the body absorbs different tablet forms, whether food affects absorption, and how it interacts with other common medications. The study involved 126 healthy volunteers to gather basic safety and interaction data before testing in people with HIV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Lenexa, Kansas, 66219, United States
-
GSK Investigational Site
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.